← FDA Drug Approvals (Drugs@FDA)

EMTRICITABINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2023-03-15

Drug application

FDA Application #

ANDA079188

Application type

Abbreviated New Drug Application (Generic)

Brand name

EMTRICITABINE

Generic name

EMTRICITABINE

Active ingredients

EMTRICITABINE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

AUROBINDO PHARMA LTD

Manufacturer

Aurobindo Pharma Limited

First approval

2023-03-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown